Morgan Stanley Panbela Therapeutics, Inc. Transaction History

Morgan Stanley

  • $1.23 Trillion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$0.07 - $0.16 $828 - $1,893
-11,836 Reduced 26.7%
32,500 $2,000
Q3 2022

Nov 14, 2022
BUY
$0.24 - $1.4 $7,640 - $44,570
31,836 Added 254.69%
44,336 $12,000
Q2 2022

Aug 15, 2022
BUY
$0.61 - $2.1 $7,625 - $26,250
12,500 New
12,500 $8,000

Others Institutions Holding PBLA

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Panbela Therapeutics, Inc.

PBLA Quotes by TradingView
  • Ticker PBLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,774,000
  • Market Cap $7.69M
  • Description
  • Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer...
More about PBLA
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email